Evaluation of Ocoxin®-Viusid® in Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Breast Carcinoma|Adriamycin Toxicity|Cyclosporine Toxicity
Interventions: COMBINATION_PRODUCT: CT + Ocoxin-Viusid|COMBINATION_PRODUCT: CT + Placebo
Sponsor: Catalysis SL